天目药业：子公司取得换发后的《药品生产许可证》

Core Viewpoint - Tianmu Pharmaceutical's subsidiary has received a renewed drug production license, ensuring its normal operations without significant impact on the company's performance [1] Group 1 - Tianmu Pharmaceutical's wholly-owned subsidiary, Huangshan Tianmu Pharmaceutical Co., Ltd., has been issued a new drug production license by the Anhui Provincial Drug Administration [1] - The license number is皖20160182 and is valid until December 31, 2030 [1] - The renewal of the license guarantees the normal production and operation of the subsidiary [1]